Deciphera Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Deciphera Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q1 2024.
  • Deciphera Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $30.9M, a 12.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $30.9M -$4.52M -12.8% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $32.1M -$4.47M -12.2% Dec 31, 2023 10-Q 2024-05-10
Q3 2023 $33.2M -$4.43M -11.8% Sep 30, 2023 10-Q 2023-10-30
Q2 2023 $34.3M -$4.34M -11.2% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $35.4M -$401K -1.12% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $36.5M -$253K -0.69% Dec 31, 2022 10-K 2024-02-07
Q3 2022 $37.6M +$3.36M +9.81% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $38.7M +$3.55M +10.1% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $35.8M -$33K -0.09% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $36.8M +$459K +1.26% Dec 31, 2021 10-K 2023-02-07
Q3 2021 $34.3M -$2.9M -7.79% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $35.1M +$15M +74.8% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $35.9M +$15.2M +73.9% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $36.3M +$15.2M +71.8% Dec 31, 2020 10-K 2022-02-08
Q3 2020 $37.2M +$36.6M +7021% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $20.1M +$19.6M +4122% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $20.6M +$20M +2979% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $21.2M +$21.2M Dec 31, 2019 10-K 2021-02-09
Q3 2019 $522K Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $476K Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $670K Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.